Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview
- PMID: 32480216
- DOI: 10.1016/j.biopha.2020.110308
Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview
Abstract
With the advancement of science and technology, the living standards of human beings have continuously improved, but the incidence and mortality from atherosclerosis worldwide have also increased by year. Although interventional surgery and the continuous development of new drugs have significant therapeutic effects, their side effects cannot be ignored. Polydatin, an active ingredient isolated from the natural medicine Polygonum cuspidatum, has been shown to have a prominent role in the treatment of cardiovascular diseases. Polydatin treats atherosclerosis mainly from three aspects: anti-inflammatory, regulating lipid metabolism and anti-oxidative stress. This article will review the pharmacological mechanism of polydatin in anti-atherosclerosis, the biological characteristics of Polygonum cuspidatum, the toxicology and pharmacokinetics of polydatin and will provide ideas for further research.
Keywords: Anti-Inflammatory; Anti-Oxidative stress; Atherosclerosis; Polydatin; Polygonum cuspidatum.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no conflicts of interest.
Similar articles
-
Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis.Life Sci. 2020 Aug 1;254:117756. doi: 10.1016/j.lfs.2020.117756. Epub 2020 May 7. Life Sci. 2020. PMID: 32389832 Review.
-
Polydatin alleviated alcoholic liver injury in zebrafish larvae through ameliorating lipid metabolism and oxidative stress.J Pharmacol Sci. 2018 Sep;138(1):46-53. doi: 10.1016/j.jphs.2018.08.007. Epub 2018 Sep 7. J Pharmacol Sci. 2018. PMID: 30245287
-
Nutraceutical therapies for atherosclerosis.Nat Rev Cardiol. 2016 Sep;13(9):513-32. doi: 10.1038/nrcardio.2016.103. Epub 2016 Jul 7. Nat Rev Cardiol. 2016. PMID: 27383080 Free PMC article. Review.
-
Inflammation and atherosclerosis: what is on the horizon?Heart. 2020 Jan;106(1):80-85. doi: 10.1136/heartjnl-2018-314230. Heart. 2020. PMID: 31843811 Review. No abstract available.
-
The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):483-493. doi: 10.1177/1074248418778548. Epub 2018 May 21. J Cardiovasc Pharmacol Ther. 2018. PMID: 29783850 Review.
Cited by
-
Polydatin reverses oxidation low lipoprotein (oxLDL)-induced apoptosis of human umbilical vein endothelial cells <em>via</em> regulating the miR-26a-5p/BID axis.Eur J Histochem. 2022 Sep 20;66(4):3505. doi: 10.4081/ejh.2022.3505. Eur J Histochem. 2022. PMID: 36128773 Free PMC article.
-
Polydatin alleviates bleomycin-induced pulmonary fibrosis and alters the gut microbiota in a mouse model.J Cell Mol Med. 2023 Dec;27(23):3717-3728. doi: 10.1111/jcmm.17937. Epub 2023 Sep 4. J Cell Mol Med. 2023. PMID: 37665061 Free PMC article.
-
Polydatin combined with hawthorn flavonoids alleviate high fat diet induced atherosclerosis by remodeling the gut microbiota and glycolipid metabolism.Front Pharmacol. 2025 Mar 3;16:1515485. doi: 10.3389/fphar.2025.1515485. eCollection 2025. Front Pharmacol. 2025. PMID: 40098615 Free PMC article.
-
Impact of Phytochemicals on PPAR Receptors: Implications for Disease Treatments.PPAR Res. 2022 Aug 31;2022:4714914. doi: 10.1155/2022/4714914. eCollection 2022. PPAR Res. 2022. PMID: 36092543 Free PMC article. Review.
-
Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target.Int J Mol Sci. 2021 Dec 22;23(1):77. doi: 10.3390/ijms23010077. Int J Mol Sci. 2021. PMID: 35008500 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical